Experts and health authorities say that while the risk of human infection with the H5N1 strain of avian influenza remains low ...

Health Canada has authorized three influenza vaccines that could be used if bird flu became a pandemic, the agency says.

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

2:12 H5N1 avian influenza: B.C. reports 1st suspected human case of bird flu Health Canada has authorized three influenza vaccines that could be used if bird flu became a pandemic, the agency says.

Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Canada’s panel of vaccine advisers has strongly recommended the new vaccines targeting the KP.2 strain, part of the Omicron lineage, for the previously vaccinated or unvaccinated at increased risk of ...

Health Canada has approved the vaccine, mRESVIA, for the prevention of lower respiratory tract disease in older adults, the company said.

Human-to-human transmission is very rare, but as cases among animals rise, many experts are worried the virus could develop ...

The global health agency said on Wednesday the newly allocated vaccines will go to the Central African Republic, Ivory Coast, the Democratic Republic of Congo, Kenya, Liberia, Nigeria, Rwanda, South A ...

GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent lower respiratory tract disease ...